← Back to Search

LGBTQ+ Training for Mental Health Care Improvement (UMD-PRC Trial)

N/A
Waitlist Available
Led By Bradley Boekeloo
Research Sponsored by University of Maryland, College Park
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30 days after therapist completion of the intervention, an average of 6 months after enrollment.
Awards & highlights
No Placebo-Only Group

Summary

This trial will improve LGBT mental health care by using the Sexual and Gender Diversity Learning Community (SGDLC) program and 5 evidence-based tools.

Who is the study for?
This trial is for therapists in Maryland who are at least 18, speak English, and are licensed or getting licensed to provide mental healthcare. They must work with a participating organization and have a minimum of 10 clients over the age of 16.
What is being tested?
The study tests if online and face-to-face LGBTQ+ training improves therapist competency. It measures changes in LGBT-friendly policies, clinician practices, client satisfaction, health literacy, and performance with standardized LGBT patient actors.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not applicable. However, participants may experience stress or discomfort during learning processes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 days after therapist completion of the intervention, an average of 6 months after enrollment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30 days after therapist completion of the intervention, an average of 6 months after enrollment. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Virtual Simulated Client Skill Assessment

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: On-line resourcesExperimental Treatment1 Intervention
The Comparison Intervention arm receives only links to publicly available on-line resources.
Group II: Face-to-face and online LGBTQ training+Experimental Treatment1 Intervention
The Study Intervention arm receives the organization-level LGBTQ climate assessment and technical assistance, the provider-level face-to-face LGBTQ training along with links to publicly available on-line training.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
On-line training
2020
N/A
~3820

Find a Location

Who is running the clinical trial?

University of Maryland, College ParkLead Sponsor
158 Previous Clinical Trials
45,768 Total Patients Enrolled
Bradley BoekelooPrincipal InvestigatorUniversity of Maryland

Media Library

Face-to-face and online LGBTQ+ training Clinical Trial Eligibility Overview. Trial Name: NCT05352659 — N/A
Gender Dysphoria Research Study Groups: On-line resources, Face-to-face and online LGBTQ training+
Gender Dysphoria Clinical Trial 2023: Face-to-face and online LGBTQ+ training Highlights & Side Effects. Trial Name: NCT05352659 — N/A
Face-to-face and online LGBTQ+ training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05352659 — N/A
~129 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top